Webinar
16:00-17:00, 27 April 2022 (GMT+8 China Time)
In the current field of pharmaceutical research and development (R&D), cell and gene therapy is regarded as a new round of technological revolution that the industry is ushering in. Compared with traditional chemical drugs and antibody drugs, it has the advantages of single treatment and long-term benefits. Therefore, it has received more and more attention from scientific research, pharmaceutical development, and clinical application. To promote product research and development in the field of cell and gene therapy in China, CPHI & PMEC China join hands with PharmaSources to launch “Bio Insights: Cell and Gene Therapy Webinar ”. This online webinar will invite entrepreneurs and scholars from international biopharmaceutical companies, scientific research institutions, and equipment companies to conduct in-depth sharing and discussion focusing on new cell and gene therapies represented by CAR-T, presenting advanced technologies and trends, as well as cases of implementation practice. It aims to accelerate the development process of the biopharmaceutical industry and foster the continuous innovation of China’s biopharmaceuticals.
PhD. Cameron Bardliving
Director of Operations
Jefferson Institute for Bioprocessing
Thomas Jefferson University
Dr. Peter Shapiro
Senior Director
GlobalData
Peter Shapiro, PhD, is Senior Director of the Drugs Database and Platform Integration and also serves as the Editor-in-Chief of PharmSource. He has worked on the integration of BioPharm Insight, Lead Sheet, PharmSource, and IHS Markit into GlobalData's Pharma Intelligence Center. Peter holds a PhD in Molecular and Cellular Biology from the Vilcek Institute of New York University and is located in GlobalData's office in New York City. Prior to joining GlobalData, Peter was an Assistant Manager at Target Health, a Contract Research Organization where he helped a diverse set of clients with the demands of bringing biologics, devices, and drugs to the market successfully. Peter also worked in small molecule drug development for Abbott Labs and on in vitro diagnostics at Ambergen, a diagnostic startup.
Trends in Cell and Gene Therapy pipeline and approvals
Trends and issues in Cell and Gene Therapy Contract Manufacturing
The complexities of bioprocessing and manufacturing of biologics















JENNIFER YANG
+86-21-3339 2533
Jennifer.Yang@imsinoexpo.com
FEATURED
HOSTED BUYERS